These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33918456)

  • 1. Relationship between NAFLD and Periodontal Disease from the View of Clinical and Basic Research, and Immunological Response.
    Hatasa M; Yoshida S; Takahashi H; Tanaka K; Kubotsu Y; Ohsugi Y; Katagiri T; Iwata T; Katagiri S
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies.
    Aguiar ILS; Santos-Lins LS; Brasil-Oliveira R; Cotrim HP; Lins-Kusterer L
    Arab J Gastroenterol; 2023 Nov; 24(4):198-203. PubMed ID: 37993376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease.
    Yoneda M; Naka S; Nakano K; Wada K; Endo H; Mawatari H; Imajo K; Nomura R; Hokamura K; Ono M; Murata S; Tohnai I; Sumida Y; Shima T; Kuboniwa M; Umemura K; Kamisaki Y; Amano A; Okanoue T; Ooshima T; Nakajima A
    BMC Gastroenterol; 2012 Feb; 12():16. PubMed ID: 22340817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.
    Kuraji R; Sekino S; Kapila Y; Numabe Y
    Periodontol 2000; 2021 Oct; 87(1):204-240. PubMed ID: 34463983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of
    Wang T; Ishikawa T; Sasaki M; Chiba T
    Front Med (Lausanne); 2022; 9():822190. PubMed ID: 35308549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Liu L; Geng Y; Xiong C
    Ann Med; 2023; 55(2):2255825. PubMed ID: 37708866
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review.
    Kobayashi T; Iwaki M; Nogami A; Honda Y; Ogawa Y; Imajo K; Saito S; Nakajima A; Yoneda M
    Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.
    Sato S; Kamata Y; Kessoku T; Shimizu T; Kobayashi T; Kurihashi T; Takashiba S; Hatanaka K; Hamada N; Kodama T; Higurashi T; Taguri M; Yoneda M; Usuda H; Wada K; Nakajima A; Morozumi T; Minabe M
    Sci Rep; 2022 Aug; 12(1):13621. PubMed ID: 35948584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
    Kamata Y; Kessoku T; Shimizu T; Kobayashi T; Kurihashi T; Sato S; Kuraji S; Aoyama N; Iwasaki T; Takashiba S; Hamada N; Kodama T; Tamura T; Ino S; Higurashi T; Taguri M; Yamanaka T; Yoneda M; Usuda H; Wada K; Nakajima A; Minabe M
    Trials; 2020 Mar; 21(1):291. PubMed ID: 32293522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis.
    Kuraji R; Ye C; Zhao C; Gao L; Martinez A; Miyashita Y; Radaic A; Kamarajan P; Le C; Zhan L; Range H; Sunohara M; Numabe Y; Kapila YL
    NPJ Biofilms Microbiomes; 2024 Jan; 10(1):3. PubMed ID: 38233485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis.
    Yao C; Lan D; Li X; Wang Y; Qi S; Liu Y
    Microbes Infect; 2023; 25(1-2):105040. PubMed ID: 35987459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis.
    Gibson FC; Yumoto H; Takahashi Y; Chou HH; Genco CA
    J Dent Res; 2006 Feb; 85(2):106-21. PubMed ID: 16434728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between periodontal disease, tooth loss and liver diseases risk.
    Chen Y; Yang YC; Zhu BL; Wu CC; Lin RF; Zhang X
    J Clin Periodontol; 2020 Sep; 47(9):1053-1063. PubMed ID: 32621350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review.
    Alakhali MS; Al-Maweri SA; Al-Shamiri HM; Al-Haddad K; Halboub E
    Clin Oral Investig; 2018 Dec; 22(9):2965-2974. PubMed ID: 30357481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-Induced Non-alcoholic Fatty Liver Disease and Associated Gut Dysbiosis Are Exacerbated by Oral Infection.
    Simas AM; Kramer CD; Genco CA
    Front Oral Health; 2021; 2():784448. PubMed ID: 35141703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan.
    Iwasaki T; Hirose A; Azuma T; Ohashi T; Watanabe K; Obora A; Deguchi F; Kojima T; Isozaki A; Tomofuji T
    Sci Rep; 2018 May; 8(1):7496. PubMed ID: 29760403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.